Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study
Yıl: 2022 Cilt: 60 Sayı: 2 Sayfa Aralığı: 168 - 174 Metin Dili: İngilizce DOI: 10.4274/haseki.galenos.2022.7941 İndeks Tarihi: 21-06-2022
Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study
Öz: Aim: There is no study predicts the development of complications with laboratory parameters in patients with primary hyperparathyroidism
(PHPT). We aimed to determine the laboratory parameters that predict the development of osteoporosis or nephrolithiasis in patients
with PHPT and identify high-risk patients.
Methods: This multicenter retrospective cross-sectional study was conducted between January 2018 and January 2020. The study
group consisted of 389 patients who were diagnosed with PHPT (68 patients without surgical indications and 321 patients with PHPT
who underwent surgery), and 451 individuals without any additional disease as a control group. Patients’ data was obtained from the
hospital automation system. All patients were divided into three groups (control, unoperated and operated), and laboratory parameters
were compared.
Results: The Wisconsin index (WIN), which is used to detect hyperfunctional glands in addition to parathyroid adenoma in PHPT, and
the Parathyroid functional index (PFIndex), which is used to differentiate HPT secondary to vitamin D deficiency, can identify patients
at high risk of nephrolithiasis or osteoporosis in patients with PHPT. In patients who have been operated on due to PHPT-related
complications, the WIN value of 283.29 showed 95% sensitivity and 72% specificity in predicting osteoporosis, while the PFIndex of
36.43 had 86% sensitivity and 68% specificity for predicting nephrolithiasis.
Conclusion: The WIN and PFIndex can be used to refer patients with PHPT for surgery before the onset of osteoporosis or nephrolithiasis.
Although no risk factor could be found for nephrolithiasis, WIN was found as an independent risk factor for osteoporosis.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Madeo B, Kara E, Cioni K, et al. Serum calcium to phosphorous (ca/p) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR Plus 2018;2:109-17.
- 2. Glendenning P, Bell DA, Clifton-Bligh RJ. Investigating hypophosphataemia. BMJ 2014;348:g3172.
- 3. Salcuni AS, Battista C, Pugliese F, et al. Normocalcemic primary hyperparathyroidism: an update. Minerva Endocrinologica 2020;46:262-71.
- 4. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nature Reviews Endocrinology 2018;14:115-25.
- 5. Zhu CY, Sturgeon C, Yeh MW. Diagnosis and Management of Primary Hyperparathyroidism. Jama 2020;323:1186-7.
- 6. Sencar ME, Sakiz D, Unsal IO, et al. Serum Vitamin D Level Does not Affect The Sensitivity of Parathyroid Adenoma Localization Tests. Scientific Reports 2019;9:1-6.
- 7. Guo Y, Wang Q, Lu C, et al. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study. BMC Endocrine Disorders 2020;20:5.
- 8. Muñoz de Nova JL, Sampedro-Nuñez M, Huguet-Moreno I, Marazuela Azpiroz M. A practical approach to normocalcemic primary hyperparathyroidism. Endocrine 2021;74:235-44.
- 9. Mazeh H, Chen H, Leverson G, Sippel RS. Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Annals of Surgery 2013;257:138-41.
- 10. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014;99:3561-9.
- 11. Cormier C, Koumakis E. Bone and primary hyperparathyroidism. Jt Bone Spine 2022;89:105129.
- 12. De Pasquale L, Lori E, Bulfamante AM, Felisati G, Castellani L, Saibene AM. Evaluation of Wisconsin and CaPTHUS Indices Usefulness for Predicting Monoglandular and Multiglandular Disease in Patients with Primary Hyperparathyroidism through the Analysis of a Single-Center Experience. Int J Endocrinol 2021;2021.
- 13. Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med 2019;285:149-64.
- 14. Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 2017;55:256-65.
- 15. Gollisch K, Siggelkow H. Asymptomatischer primärer Hyperparathyreoidismus. Der Internist 2021;62:496-504.
- 16. Lundstam K, Heck A, Mollerup C, et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2015;100:1359-67.
- 17. Nordenström E, Westerdahl J, Lindergård B, Lindblom P, Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 2002;26:1463-7.
- 18. Reid LJ, Muthukrishnan B, Patel D, Seckl JR, Gibb FW. Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism. J Clin Endocrinol Metab 2019;104:3692-700.
- 19. Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G. Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 2015;100:3069-73.
- 20. Huang S-Y, Burchette R, Chung J, Haigh PI. Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea. Surgery 2022;171:29-34.
- 21. Marchini GS, Faria KV, Torricelli FC, et al. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy. BJU international 2018;121:281-8.
- 22. Clarke BL. Asymptomatic primary hyperparathyroidism. Parathyroid Disorders. 51: Karger Publishers; 2019. p. 13-22
APA | başer ö, Köseoğlu D, cetin z, Çatak M (2022). Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. , 168 - 174. 10.4274/haseki.galenos.2022.7941 |
Chicago | başer özden,Köseoğlu Derya,cetin zeynep,Çatak Merve Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. (2022): 168 - 174. 10.4274/haseki.galenos.2022.7941 |
MLA | başer özden,Köseoğlu Derya,cetin zeynep,Çatak Merve Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. , 2022, ss.168 - 174. 10.4274/haseki.galenos.2022.7941 |
AMA | başer ö,Köseoğlu D,cetin z,Çatak M Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. . 2022; 168 - 174. 10.4274/haseki.galenos.2022.7941 |
Vancouver | başer ö,Köseoğlu D,cetin z,Çatak M Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. . 2022; 168 - 174. 10.4274/haseki.galenos.2022.7941 |
IEEE | başer ö,Köseoğlu D,cetin z,Çatak M "Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study." , ss.168 - 174, 2022. 10.4274/haseki.galenos.2022.7941 |
ISNAD | başer, özden vd. "Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study". (2022), 168-174. https://doi.org/10.4274/haseki.galenos.2022.7941 |
APA | başer ö, Köseoğlu D, cetin z, Çatak M (2022). Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni, 60(2), 168 - 174. 10.4274/haseki.galenos.2022.7941 |
Chicago | başer özden,Köseoğlu Derya,cetin zeynep,Çatak Merve Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni 60, no.2 (2022): 168 - 174. 10.4274/haseki.galenos.2022.7941 |
MLA | başer özden,Köseoğlu Derya,cetin zeynep,Çatak Merve Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni, vol.60, no.2, 2022, ss.168 - 174. 10.4274/haseki.galenos.2022.7941 |
AMA | başer ö,Köseoğlu D,cetin z,Çatak M Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni. 2022; 60(2): 168 - 174. 10.4274/haseki.galenos.2022.7941 |
Vancouver | başer ö,Köseoğlu D,cetin z,Çatak M Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni. 2022; 60(2): 168 - 174. 10.4274/haseki.galenos.2022.7941 |
IEEE | başer ö,Köseoğlu D,cetin z,Çatak M "Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study." Haseki Tıp Bülteni, 60, ss.168 - 174, 2022. 10.4274/haseki.galenos.2022.7941 |
ISNAD | başer, özden vd. "Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study". Haseki Tıp Bülteni 60/2 (2022), 168-174. https://doi.org/10.4274/haseki.galenos.2022.7941 |